Transpara vs Chest-CAD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Transpara

by ScreenPoint Medical

Chest-CAD

by Imagen Technologies

AI Verdict

Transpara and Chest-CAD are adjacent competitors as both are FDA-cleared AI solutions for radiology, aiming to enhance detection and optimize workflow. However, Transpara specializes in breast cancer detection using mammography (2D and 3D), while Chest-CAD focuses on detecting and categorizing suspicious regions on adult chest X-rays. Therefore, the choice between them depends entirely on the specific imaging modality and anatomical region requiring AI-powered analysis.

Choose Transpara if…

Choose Transpara if your primary goal is to enhance breast cancer detection and optimize radiologist workflow specifically for 2D and 3D mammography. Its advanced AI capabilities, including temporal comparison and breast density assessment, make it ideal for comprehensive breast screening programs aiming for earlier detection and reduced workload for radiologists. It's particularly well-suited for practices seeking a high negative predictive value for low-risk cases.

View Transpara →

Choose Chest-CAD if…

Choose Chest-CAD if your focus is on improving the detection and categorization of suspicious regions on adult chest X-rays, especially in settings where reducing diagnostic errors is a critical concern. Its ability to identify and categorize abnormalities across various anatomical regions on chest X-rays makes it highly valuable for emergency medicine, pulmonology, and general radiology departments seeking to augment physician accuracy and efficiency in interpreting chest radiographs.

View Chest-CAD →

When considering AI tools for diagnostic imaging, Transpara and Chest-CAD offer distinct capabilities tailored to different radiological needs. Transpara, developed by ScreenPoint Medical, specializes in breast cancer detection for both 2D and 3D mammography. Its key features include temporal comparison, analyzing current studies against prior ones, and providing breast density assessments and risk categorization. Transpara is designed to integrate into existing PACS and reading workflows, with deployment options including cloud-enabled access through Microsoft for Healthcare. It is best suited for radiology practices and imaging centers focused on mammography, aiming for earlier breast cancer detection and optimized radiologist workflow.

In contrast, Chest-CAD by Imagen Technologies focuses on detecting, categorizing, and localizing suspicious regions on adult chest X-rays. This cloud-based AI software identifies abnormalities across various categories such as Cardiac, Lungs, and Bones, and is shown to reduce diagnostic errors. Chest-CAD integrates with PACS viewers and serves as a concurrent reading aid for physicians. This tool is ideal for specialties like Emergency Medicine, Pulmonology, and Radiology departments that frequently interpret chest X-rays and seek to enhance diagnostic accuracy and reduce errors in that specific modality.

The fundamental practical difference lies in their imaging modality focus: Transpara is exclusively for mammography, while Chest-CAD is for chest X-rays. Physicians should choose Transpara if their primary need is to enhance breast cancer detection and streamline mammography workflows. Conversely, Chest-CAD is the appropriate choice for those seeking to improve the accuracy and efficiency of chest X-ray interpretations.

Quick Comparison

Feature	Transpara	Chest-CAD
Pricing	Unknown	Contact for pricing
Deployment	Transpara integrates into PACS and reading workflows via medical-imaging (DICOM) pipelines. It is also available through Precision Imaging Network, part of Microsoft for Healthcare, which simplifies deployment pathways for cloud-enabled access within existing clinical ecosystems.	Cloud-based
FDA Status	Cleared AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Transpara

Transpara integrates directly into existing PACS and reading workflows via DICOM, and is also available through Microsoft for Healthcare's Precision Imaging Network, simplifying cloud-enabled access. This deep integration suggests a smoother user experience within established clinical environments. While Chest-CAD also integrates with PACS viewers, Transpara's broader deployment options and focus on workflow optimization for radiologists, including workload reduction, suggest a more refined and user-centric design.

Clinical Value

Transpara

Transpara has a more extensive body of clinical evidence, including being the first breast AI solution validated by a randomized controlled trial (MASAI trial), which demonstrated a 29% increase in cancer detection and a 44% workload reduction. While Chest-CAD has shown a 40% reduction in diagnostic errors in clinical studies, Transpara's robust validation across various studies and its specific features like temporal comparison and risk categorization for breast cancer provide a broader and more thoroughly supported clinical value.

Pricing & Value

Tie

Both tools require direct contact for pricing, which limits transparency. While Transpara has a study suggesting cost-effectiveness and QALY gains, specific pricing models for either tool are not publicly available. Without concrete pricing information, it's impossible to definitively determine which offers better value.

Enterprise Readiness

Transpara

Transpara is deployed in over 30 countries and has analyzed over 13 million mammograms, indicating a proven track record of large-scale enterprise adoption and stability. Its integration with Microsoft for Healthcare further solidifies its enterprise readiness. Chest-CAD's cloud-based deployment and HIPAA compliance are positive, but its customer count and global reach are not specified, making Transpara appear more established for large-scale deployments.

Innovation

Transpara

Transpara offers advanced features like temporal comparison (analyzing current studies against up to 3 priors over 6 years) and both BI-RADS-like and volumetric breast density assessment, which are innovative in enhancing breast cancer detection. While Chest-CAD utilizes deep learning for ROI detection and categorization on chest X-rays, Transpara's specialized features for mammography demonstrate a more focused and advanced innovation within its specific domain.

Support & Docs

Transpara

Transpara's website mentions proactive support, frequent updates (every 10 days with new features), remote training, and direct assistance from engineers, along with a free 30-day trial. While Chest-CAD's documentation is not explicitly detailed, Transpara's comprehensive and transparent approach to support and documentation suggests a stronger offering in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Transpara	Chest-CAD
Name	Transpara	Chest-CAD
Company	ScreenPoint Medical	Imagen Technologies
Description	Transpara is an FDA-cleared AI solution by ScreenPoint Medical B.V. that enhances breast cancer detection and optimizes radiologist workflow for 2D and 3D mammography.	Chest-CAD by Imagen Technologies is an FDA-cleared AI software that detects, categorizes, and localizes suspicious regions on adult chest X-rays, shown to reduce diagnostic errors by 40%.
Categories	Clinical Decision Support & Reference, Radiology & Imaging AI	Clinical Decision Support & Reference, Radiology & Imaging AI
Specialties	Obstetrics & Gynecology, Radiology	Emergency Medicine, Pulmonology, Radiology
Key Features	AI-powered detection for 2D and 3D mammograms (FFDM and DBT), Temporal Comparison (analyzes current study against up to 3 priors over 6 years), Breast Density assessment (BI-RADS-like and volumetric), Risk categorization (Elevated, Intermediate, Low), Region-based and overall exam scores, Workflow optimization and workload reduction, Concurrent reading aid for radiologists, High negative predictive value for low-risk cases (99.97%)	AI-powered detection and categorization of ROIs on chest X-rays, Identifies suspicious regions in categories: Cardiac, Mediastinum/Hila, Lungs, Pleura, Bones, Soft Tissues, Hardware, Other, Reduces diagnostic errors by 40% in clinical studies, Concurrent reading aid for physicians, Integrates with Picture Archiving and Communication System (PACS) viewers, Cloud-based processing and delivery, Deep learning algorithms for computer vision, Provides bounding boxes and labels for detected ROIs
API Available	yes	Not specified

Videos

Demos, reviews, and walkthroughs featuring Transpara and Chest-CAD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing radiology workflows and EHR systems?

Transpara integrates into PACS and reading workflows via DICOM pipelines and is also available through the Precision Imaging Network, part of Microsoft for Healthcare, to simplify cloud-enabled access within existing clinical ecosystems. Chest-CAD integrates with Picture Archiving and Communication System (PACS) viewers. While general EHR systems may require workarounds for cardiology, the integration of CAD systems within EHRs is an ongoing area of focus to provide a comprehensive working environment for radiologists.

What are the reported accuracy and sensitivity of each tool in a clinical setting?

Transpara has shown improved radiologist accuracy in reading 3D mammograms, with studies reporting improved sensitivity (86% vs 81%) without increasing reading time. It also demonstrated similar AI-based screening sensitivity to radiologists (69.7% vs 70.8%) while reducing false positives by 25.1% in a large Danish screening program. Chest-CAD achieved an AUC of 97.6%, with sensitivity at 90.8% and specificity at 88.7% in detecting chest X-ray abnormalities, and significantly improved the accuracy of both radiologists and non-radiologist physicians.

What is the typical learning curve for physicians adopting these AI tools?

Transpara is designed to work concurrently with radiologists, acting as a 'second pair' of eyes to help detect cancers earlier and reduce workload. Its workflow includes categorizing exams by risk and highlighting suspicious areas, with low-risk cases unmarked for expedited review, which can reduce review time. Chest-CAD is described as a concurrent reading aid for physicians, providing bounding boxes and labels for detected regions of interest, suggesting a supportive role rather than a complete replacement of diagnostic interpretation. Both tools aim to enhance, rather than replace, physician expertise, which generally implies a learning curve focused on integrating the AI's output into existing diagnostic processes.

What kind of customer support can physicians expect for these tools?

ScreenPoint Medical offers customer support for Transpara via email and phone, with dedicated numbers for EMEA and USA. They emphasize a willingness to help with any questions, offering quick web meetings to address issues live. Information on Chest-CAD's specific customer support quality is not detailed, but generally, companies offering AI solutions for clinical use provide support to ensure proper integration and functionality.

How quickly can a practice expect to see value after implementing these tools?

Transpara deployments are measured in days and weeks, not months and years, with no-code configuration aiming to eliminate the need for large development teams. Some customers have reported realizing ROI in less than 6 months. The goal is to create benefits within weeks of choosing Transpara. While specific time-to-value for Chest-CAD is not provided, AI solutions generally aim to deliver tangible benefits quickly after implementation, such as reducing diagnostic errors and optimizing workflow.

What audit-trail features are available to track the AI's contribution to diagnoses?

Transpara provides region-based and overall exam scores, risk categorization (Elevated, Intermediate, Low), and can mark up to two areas of concern per breast. This detailed scoring and marking can contribute to an audit trail by documenting the AI's assessment. For Chest-CAD, it provides bounding boxes and labels for detected suspicious regions, which would also serve as a record of the AI's findings. These features allow for tracking the AI's input alongside the physician's final interpretation.

What are the considerations for rolling out these tools across multiple clinical sites or a large health system?

Transpara is deployed in over 30 countries and has been used to analyze over 13 million mammograms worldwide, indicating its scalability for multi-site rollouts. Its integration via DICOM pipelines and availability through Microsoft for Healthcare's Precision Imaging Network simplifies deployment across existing clinical ecosystems. Chest-CAD is cloud-based, which generally facilitates multi-site deployment and access. Multi-location support for EHR systems, which these tools integrate with, often includes shared protocol management and per-site workflow configuration.